Showing results (51-60 of 541) with videos related to
Sort By:
Pageof 55
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|September 1, 1993
MASH genes and the logic of neural crest cell lineage diversificationD J AndersonThe Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.Journal of Geriatric Psychiatry and Neurology|October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1995
The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's diseaseJ J Sramek, N R Cutler, D J Hurley, et al.Anxiety|January 1, 1994
Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findingsJ J Sramek, M S Kramer, S A Reines, et al.The Annals of Pharmacotherapy|September 1, 1992
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefitEzio Giacobini, R Spiegel, A Enz, et al.Alzheimer Disease and Associated Disorders|January 1, 1995
Orthostasis in Alzheimer disease: a retrospective analysisS S Jhee, J J Sramek, T S Wardle, et al.Depression and Anxiety|June 5, 1999
Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxietyJ J Sramek, W W Hong, S Hamid, et al.Hospital & Community Psychiatry|June 1, 1991
Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patientsJ Sramek, S Roy, T Ahrens, et al.Pageof 55